BDNF and Alzheimer disease: With the administration of donepezil, a decrease in the expression level of miR-206-3p was observed, suggesting that miR-206 could be a possible target for developing novel therapies for AD as a higher level of miR-206 was associated with downregulation of brain-derived neurotrophic factor (BDNF).